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EXPERIMENTAL BIOLOGY GROUP : SUMMARIES OF SCIENTIFIC PAPERS
The following are summaries of the papers presented at the 16th Scientific Meeting of the Experimental Biology Group
(EBG) held on 30 April 1965 in the Lower Lecture Room, Department of Pathology, Medical School, University of Cape
Town.
THE EFFECTS OF HISTAMI E A D 5-HT LIBERATORS 0 r EXPERIMENTAL NO -DIETARY
CIRRHOSIS I r RATS
J. A. H. CAMPBELL, Department of Pathology, University of Cape Town Medical School
The experimental cirrhosis produced in rats by intravenous
injections of egg-yolk or other foreign protein, suffers from
being non-progressive, even when intensified by adrenalectomy.
If the animals are depleted of histamine before egg-yolk injec-
tions are commenced, and a histamine liberator given with all
subsequent egg-yolk injections, a more sustained lesion is pro-
duced, though its onset may be delayed. This apparently pro-
gressive lesion is accompanied by unusual degrees of hepato-
megaly, focal hepatic necrosis and, exceptionally, bile ductular
proliferation.
Depleting the animals of 5-HT with reserpine during the
course of egg-yolk injections gives variable results, but large
and toxic doses intravenously appear to prevent egg-yolk
fibrosis in about one-half the animals tested.
SOME EFFECTS OF PEPTIDES ON MICROSOMAL PROTEIN SY TTHESIS
M. C. BERMAN, C5lR Protein Research Unit, Department of Chemical Pathology, University of Cape Town
The exact role of peptides in cellular metabolism or in protein
synthesis has not been clearly defined. Currently accepted
mechanisms do not provide for the participation of preformed
peptides in protein synthesis. There is, however, evidence,
mainly from plants' and from bacteria,' that peptides are able
to influence protein synthesis or function as protein precursors.
Srudies on peptide excretion in children during protein deple-
tion and repletion have suggested that peptides may be inter-
mediates during protein synthesis.'
In order to obtain more direct evidence on the role of
peptides, their effect has been studied on in vivo protein synthe-
sis using a system from rat liver. Homogenized liver from
fasting rats was separated by differential centrifugation into
nuclear, mitochondrial microsomal and a supematant fraction,
from which a 'pH 5' enzyme precipitate was prepared: On
incubating "C-L-Ieucine in a suitable salt mixrure, with an
energy generating system and either supematant or 'pH 5'
fractions, microsomal protein was labelled and its specific HC
activity measured. With this system gly-I-Ieu (6 x IO"M) caused
5Iob inhibition of HC-leucine uptake. The degree of inhibition
was proportional to log (peptide concentration). Other peptides
at a concentration of 6 x 10"M had the following effects on
incorporation: I-Ieu. gly. + I 1%, I-ala. leu. + 5~~, gly. gly.
gly. - II o~, gly. I-tyr. - 17%, gly. gly. - 39°~.
The possibility that hydrolysis of leucyl peptides, with con-
sequent dilution of the HC amino acid with unlabelled leucine,
could contribute to the effects, was also investigated. The
activity of glycyl-I-Ieucine peptidase in the various fractions
was (in units/mg. protein): whole homogenate 0·67, nuclei
0·014, microsomes 0·11, supernatant 1·95 and pH 5 fraction
0·080. Equimolar (6 x 10"M) I-leucine produced less inhibition
(35%) than gly-Ieu. Dilution of the HC label was, therefore, not
the only mechanism of inhibition nor could it account for
slight activation by some peptides and the inhibition by pep-
tides containing no leucine.
Apart from these unexplained phenomena it appears that
peptides can compete with free amino acids for incorporation
into protein, and thus may exert an important influence on
the entry of amino acids into the protein molecule.
Thanks are due to Prof. J. E. Kench for his helpful criticism
and discussion. The work was supported in part by the UCT
Cancer Research Fund and the South African Atomic Energy
Board.
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SEROLOGICAL STUDIES OF BROME-GRASS MOSAIC VIRUS AND ITS PROTEI FRAGMENTS
BARBARA M. VON WECHMAR Al'.'D M. H. V. VAN REGENMORTEL, Department of Microbiology, Universiry of 5tellenbosch
Brome-grass mosaic virus (BMV) has been found to be wide-
spread in pasture grasses and wheat in South Africa.' This
virus has some unique properties such as an unusual RNA
composition (MW = I x 10'), an isoelectric point of pH 7·9,
and a smaller size at pH 6 than at pH 7·0.' This structural
transition is indicated by higher values of the intrinsic visco-
sity, sedimentation and diffusion coefficients of the virus at
pH 6·0.' Another characteristic property of BMV is its insta-
bility above pH 6·5, the virus being degraded into a number
of serologically related antigens with different electrophoretic
mobilities.' This phenomenon warranted a detailed investigation
of the serological behaviour of BMV and its protein frag-
ments.
A number of antisera were prepared against BMV and its
breakdown products. When virus purified in the presence of
pH 7 phosphate buffer was used to inject rabbits intramuscu-
larly, an antiserum (titre 1/64) was obtained that reacted in
gel double-diffusion tests with both complete virus particles
and with various virus degradation products. Up to 4 precipi-
tin lines were obtained in some tests when the antigen was
kept above pH 7·0 at room temperature. BMV protein with
a sedimentation coefficient of 2·8 S (a dimer of M = 40,000,
prepared by dialysis of the virus against 0·1 M CaCI, pH 6·0)
also reacted with this antiserum. forming a pattern of inter-
ference (spur) with adjacent precipitin lines caused by complete
virus particles or reaggregated protein. The position and curva-
ture of the bands helped in their identification and were used
to determine under which conditions of pH, temperature and
ionic environment the protein failed to reaggregate and the
virus to break up. Comparative diffusion measurements were
made in an analytical Tiselius cell. The virus was stabilized
in O· I M acetate buffer pH 4·0 at 4 ° and 37°C, and when
injected into rabbits it produced an antiserum that failed to
react with unaggregated BMV protein, although it reacted with
reaggregated protein. This indicates a change in the pattern of
antigenic determinants of the protein when it is assembled mto
the capsid.
It seems well established that all the protein sub-units of a
virus are structurally and chemically identical and the results
imply a change in the folding of the polypeptide chain of the
sub-units upon aggregation into virus particles. A similar con-
clusion has recently been reached by Rappaport et al.' in a
serological study of tobacco mosaic virus and turnip yellow
mosaic vi rus.
l. Von Wechmar. B. M. and Van Regenmortel, M. H. V. (1965): S. Afr.
J. Agric. Sei. (in the press). .
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THE INCORPORAno r OF 8-AMINOLAEVULI IC ACID 5-"C I TO PLASMA BILIRUBIN IN ORMAL
AND PORPHYRIC HUMA SUBJECTS
EUGEl'o'E B. DaWDLE, VCT /CSIR Renal Metabolic Research Group, Deparrmenr of Medicine, Vniversiry of Cape TOll'n
Approximately 80 !LC (4·2 m.moles) of ALA-5-"C was adminis-
tered by mouth to 2 normal subjects, one patient with South
African genetic porphyria, one patient with symptomatic
porphyria and one patient with acute intermittent (Swedish)
porphyria, and the specific activity of plasma bilirubin was
estimated at varying times thereafter for one week. In both
normal and porphyric subjects, plasma bilirubin showed a peak
in radioactivity within the first 24 hours after administration of
the radioactive ALA, without a noticeable peak at 4 days. In
the porphyric subjects, where more frequent plasma samples
were taken during the first 24 hours, this early labelled frac-
tion consistently showed two distinct peaks, the one preceding
the other by approximately 3 hours. There were no significant
differences in the time of appearance of radioactivity in
bilirubin or the specific activity of bilirubin at the peak when
normal subjects were compared with porphyrics. Since there is
good reason to believe that this early labelled fraction repre-
sents bilirubin derived from liver haem, these experiments
indicate that there is no defect in liver haem synthesis in
porphyria.
This work was supported in part by a grant, PHS A-3997,
from the ational Institute of Arthritis and Metabolic Diseases,
Public Health Service, USA.
PASSll~G EVENTS: IN DIE VERBYGAAN
*
Dr. H. Pogrund, orthopaedic surgeon, has commenced practice
at 402 Medical Centre, Heerengracht, Cape Town. Telephones:
rooms 2-2673, residence 77-3828.
Dr. H. Pogrund, ortopediese chirurg, praktiseer nou te
Mediese Sentrum 402, Heerengracht, Kaapstad. Telefone:
spreekkamer 2-2673, woning 77-3828.
Sourh African Insrilllre for Medical Research, Johannesburg,
Sraff Scielllific Meering. The next meeting will be held on
Monday 16 August at 5.10 p.m. in the Institute Lecture
Theatre. Dr. L. G. Waiters of the Pneumoconiosis Research
Unit will speak on 'Chronic bronchitis in a mining and a
non-mining community'. All interested persons will be wel-
come.
Dr. W. C. Duckworrh, specialist physician, formerly of the
Cardiac Clinic, Baragwanath Hospital, Johannesburg, and
lately consultant physician, Edendale Hospital, Pietermaritz-
burg, has commenced practice in partnership with Dr. C. P.
Dancaster at 317 Southern Life Buildings, Pietermaritzburg.
Telephones: rooms 2-1726, residence 2-4364.
Dr. W. C. Duckworrh, internis, voorheen senior registrateur
in die Hartkliniek, Baragwanath-hospitaal, Johannesburg, en
internis te Edendale-hospitaal, Pietermaritzburg, praktiseer nou
in vennootskap met dr. C. P. Dancaster te Southern Life-gebou









Associarion of Medical Srudenrs of Sourh Africa, Execurive
Commirree. The new Executive Committee of AMSSA is as
follows: Presidenr G. M. Hoosen (Natal), Vice-President J. S.
Rubenstein (Wits), Publicarions Chairman N. Donen (OCT),
Clinics Chairman 1. Dada (Natal), Finance P. Gottlieb (Wits),
Professional Exchange A. E. Simjee (Natal), Medical Educa-
rion and Films E. Oppenheimer (VCT). Mr. Hoosen will re-
present AMSSA at the IFMSA General Assembly in Edinburgh
this month.
Cape Town Paediatric Group. The next meeting will be held
on Tuesday ID August at 8.15 p.m. in the Lecture Theatre,
Red Cross War Memorial Children's Hospital, Rondebosch.
Dr. L. P. Miles will speak on 'Dentistry for paediatricians'.
All visitors will be welcome.
Universiry of Cape Town and Associarion of Surgeons of
Sourh Africa (M.A.S.A.), Joinr Leclllres. The next meeting will
be held on Wednesday II August at 5.30 p.m. in the E-floor
Lecture Theatre, Groote Schuur Hospital, Observatory, Cape.
Dr. O. L. Meyers will speak on 'Lysosomes'.
College of General Pracririoners, Cape of Good Hope Faculry.
A film evening will be held on Wednesday 11 August at 8.15
p.m. in the Physiology Lecture Theatre, Medical &hool,
Observatory, Cape. Films will be shown on: Immune reactions
in the newborn: viruses and cancer; and gait. Consultants will
be present to discuss the films and answer any questions. All
doctors will be welcome.
**
NEW PREPARATIONS AND APPLIANCES: NUWE PREPARATE EN TOESTELLE
LOCACORTEN
CIBA (Pty) Limited announce the introduction of Locacorten,
a topical corticoid, and supply the following information:
Descriprion. Locacorten (generic name flumethasone piva-
late), displays extremely rapid and potent local activity. It
exerts anti-inflammatory, anti-allergic, anti-exudative and anti-
pruritic effects, the special bases of the various forms serving
to supplement the therapeutic action of the corticoid. Loca-
corten is available as lotion, cream and ointment, the latter
two being also available with neomycin: the plain forms
contain 0·02~~ flumethasone pivalate, while the neomycin
forms contain 0.0206 flumethasone pivalate plus 0·5~0 of neo-
mycin sulphate.
Indicarions. Eczema of varying type and localization, in-
cluding infantile eczema and milk-crust; various forms of
dermatitis, including radiodermatitis, seborrhoeic dermatitis,
sunburn, otitis externa, intertrigo, and napkin rash: various
forms of neurodermatitis; skin diseases which tend to prove
resistant to other corticoids (here an occlusive dressing may be
advisable), including especially psoriasis vulgaris, lichen ruber,
and chronic discoid lupus· erythematosus.
Conrraindicarions. Tuberculosis of the skin, syphilitic skin
affections, chicken-pox, and skin eruptions following vaccina-
tion. Locacorten must not be applieQ to the conjunctiva.
Applicarion and dosage. Locacorten should be evenly
applied to the skin in a thin film, several times daily. The site
may, if necessary, be covered by a protective dressing which
should, however, permit access of air. After the skin has
healed, Locacorten should be applied at least once daily for a
further I - 2 weeks in order to prevent any recurrence of the
disease. To obtain optimum results, it is important to select
the form of application most appropriate to the stage of the
disease and the texture of the patient's skin.
Further information is obtainable from CIBA (Pty) Ltd.,
P.O. Box 92, Isando, Transvaal.
